Stockwatch Daily - - CONSUMER GOODS -

- Co­la­bor Group Inc. will re­lease its Q3 re­sults on Thurs­day, Oct. 19. The com­pany will hold a con­fer­ence call to dis­cuss the re­sults the same day at 10:30 a.m. ET. (GCL) $0.91

- Cronos Group Inc. has signed a five-year deal with G. Pohl-Boskamp GmbH for ex­clu­sive dis­tri­bu­tion of Cronos Group’s cannabis prod­ucts in Ger­many. Cronos has also closed its $15.01-mil­lion fi­nanc­ing, sell­ing 6.67 mil­lion shares at $2.25. (MJN) $3.08

- GreenPower Mo­tor Com­pany Inc. has closed the $2.22-mil­lion sec­ond and fi­nal tranche of its pri­vate place­ment of con­vert­ible deben­tures. It is seek­ing TSX-V ap­proval to fur­ther in­crease the fi­nanc­ing to $3.69-mil­lion from $3-mil­lion. (GPV) $0.39

- GreenPower Mo­tor Com­pany Inc. has re­ceived TSX-V ap­proval for a $3,696,000 con­vert­ible deben­ture pri­vate place­ment. Twenty-four placees are sub­scrib­ing. (GPV) $0.40

- The Hy­dropothe­cary Corp. hopes to com­plete the construction of its 250,000-square-foot green­house by July 1. (THCX) $1.98

- The Jean Coutu Group (PJC) Inc. earned $47.8-mil­lion on rev­enue of $744.3-mil­lion in the sec­ond quar­ter of 2017. This com­pares with earn­ings of $51.5-mil­lion on rev­enue of $701.21-mil­lion in Q2 of 2016. (PJC) $24.74

- Magna In­ter­na­tional Inc. will host a con­fer­ence call to dis­cuss its third quar­ter 2017 fi­nan­cial re­sults on Nov. 9, 2017, at 8 a.m. ET. (MG) $68.27

- Or­gan­i­gram Hold­ings Inc. has started the process for re­cer­ti­fi­ca­tion as an or­ganic pot pro­ducer with ECOCERT Canada. The com­pany hopes re­gain or­ganic cer­ti­fi­ca­tion by July, 2018. (OGI) $3.07

- Sa­puto Inc. will hold a con­fer­ence call to dis­cuss its fi­nan­cial re­sults for fis­cal Q2 2018 on Nov. 2, 2017. The call will take place at 2:30 p.m. ET. (SAP) $43.28

- True Leaf Medicine In­ter­na­tional Ltd. has con­tracted Boustead Se­cu­ri­ties to un­der­write a Reg­u­la­tion A+ of­fer­ing. The com­pany plans to raise up to $10-mil­lion in the of­fer­ing. (MJ) $0.71

- Ver­i­tas Pharma Inc. has closed its pri­vate place­ment for $1.02-mil­lion, is­su­ing 3.93 mil­lion units. It plans to use the pro­ceeds for work­ing cap­i­tal and the hu­man tri­als an­nounced on May 8, 2017. (VRT) $0.46

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.